Axsome Therapeutics Ownership & Insider Activity

Axsome Therapeutics Inc

AXSMNASDAQ

$146.13

-9.94-6.37%

마지막 업데이트: Oct 23, 12:51 PM

실적: Q3 2026 실적이 월 11월 2nd에 개장 전 10일 후 후에 발표됩니다.

Axsome Therapeutics Ownership & Insider Activity - Benzinga

Axsome Therapeutics (AXSM) institutional and insider ownership, recent insider transactions and ownership breakdown.

Net Insider Activity by Month

Date	Insider	Title	Type	Shares	Price	Value
Sep 3, 2026	Mark Jacobson	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$110.80	$2.0M
Aug 5, 2026	HERRIOT TABUTEAU	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$108.57	$10.3M
Jul 1, 2026	HERRIOT TABUTEAU	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$122.60	$11.7M
Jun 10, 2026	ROGER JEFFS	—	SELL	572.000	$247.65	$142K
Jun 9, 2026	HERRIOT TABUTEAU	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$122.98	$11.7M
Jun 9, 2026	Nick Pizzie	CHIEF FINANCIAL OFFICER	SELL-OPTIONS	—	$121.80	$7.8M
Jun 8, 2026	Susan Mahony	—	SELL-OPTIONS	829.000	$241.69	$145K
Jun 8, 2026	Mark Coleman	—	SELL-OPTIONS	786.000	$249.00	$160K
May 29, 2026	Mark Coleman	—	SELL	17.537K	$229.20	$4.0M
May 4, 2026	Mark Jacobson	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$120.45	$1.0M

Date	Member	Party	Chamber	Action	Amount
Jun 16, 2022	Chris Jacobs	R	House	Purchase	$15,001 - $50,000